New Frontiers in RPL Research and Treatment

Asher Bashiri, Avishai Shemesh, Angel Porgador, Gershon Holcberg, Maor Kabessa

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations


In the RPL field, some aspects including evaluation, diagnosis, and treatment have been controversial for many years. Research lacks randomized clinical trials as well as multicenter studies that will help enlarge the number of women inspected in each trial. In order to provide evidence-based recommendations to the couples who deal with RPL, research should take a more creative direction when investigating etiologies and treatments. Here, we focus on the most advanced research in RPL, including multifactorial approach towards RPL, heparin's role not as anticoagulant, immune systems' role, and new discoveries on different molecules. Although some of these articles are only the beginning, exposing the tip of the iceberg, and it might take a long period of time before they achieve their goals.

Original languageEnglish
Title of host publicationRecurrent Pregnancy Loss
Subtitle of host publicationEvidence-Based Evaluation, Diagnosis and Treatment
PublisherSpringer International Publishing
Number of pages18
ISBN (Electronic)9783319274522
ISBN (Print)9783319274508
StatePublished - 1 Jan 2016


  • Annexin V
  • Heparin
  • Immune system
  • Leptin
  • Multifactorial etiology
  • NK cells
  • Recurrent pregnancy loss

ASJC Scopus subject areas

  • Health Professions (all)
  • Medicine (all)


Dive into the research topics of 'New Frontiers in RPL Research and Treatment'. Together they form a unique fingerprint.

Cite this